Subjective and Objective Health in Aging: Problems of Assessment

  • L. Israël
  • Dj. Kozarevic
  • J. M. Orgogozo
Conference paper
Part of the NATO ASI Series book series (volume 9)


The purpose of this paper is to introduce concepts and findings on subjective and objective health in order to discuss problems of assessment. Three main topics are presented: concepts of health, approaches to investigation of health, problems of assessment in clinical and epidemiological practice. Findings from epidemiological and clinical investigations as well as from drug trials studies are used to illustrate problems of assessment of subjective and objective health in normal and pathological process of aging. Aims of such concepts are to enable satisfactory results either in improving health conditions, or rationalizing screening, early detection, treatment, rehabilitation and procedures of importance for better health. Such approaches are generally linked with procedures and instruments enabling to identify health in all its dimensions as well as to assess its “objective” and “subjective” sides.


Functional Ability Senile Dementia Objective Health Pathological Aging Clinical Drug Trial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abramson J H & al. (1982): Risk markers for mortality among elderly men: a community health survey in Jerusalem. 3 Chronic Dis, 35: 565–572.Google Scholar
  2. American Psychiatric Association (1980): DSM III: Diagnostic and statistical Manual of Mental Disorders, 3rd ed. Washington, DC.Google Scholar
  3. Barell V, Kaplan G (1985): Reported health of the elderly: the Kiryat Ono Census. Israel 3 Med Sciences, 21: 254–259.Google Scholar
  4. Becker P M, Cohen H J (1984): The functional approach to the care of the elderly: a conceptual framework. 3 Am Geriatr Soc, 32 (12): 923–929.Google Scholar
  5. Berthaux P, Laforestrie R (1983): Mise en evidence de l’activité thérapeutique du 5023 SE ( Duxil) sur l’efficacité intellectuelle et psychomotrice des sujets âgés détériorés. Presse Méd, 12: 852–855.Google Scholar
  6. Branconnier J & al. (1979): ACTH 4–10 in the amelioration of neuropsychological symptomatology associated with senile organic brain syndrome. Psychopharmacology, 61: 161–165.Google Scholar
  7. Brodie N H (1977): A double-blind trial of Naftidrofuryl in treating confused elderly patients in general practice. Practitionner, 218: 3–7.Google Scholar
  8. Brook R H & al. (1979): Conceptualization and measurement of health for adults in the health insurance study: vol. VIII, Overview. Washington U.S. Department of Health, Education, and Welfare (Publ. R-1987/8-HEW).Google Scholar
  9. Capote B, Parikh N (1978): Cyclandelate in the treatment of senility: a controlled study. 3 Am Geriatr Soc, 26: 360–362.Google Scholar
  10. Center for the Study of Aging and Human Development (1978): Multidimensional functional assessment: the OARS methodology, 2nd ed. Duke University, Durham, NC.Google Scholar
  11. Davies A M (1986): Epidemiological data on the health of the elderly. In: Mental Health of the Elderly, Hafner H & al. (eds). Berlin: Springer-Verlag, 15–28.Google Scholar
  12. Dawber T R (1980): The Framingham study. Cambridge, MA: Harvard University Press.Google Scholar
  13. Fanchamps A (1979): Controlled studies with dihydroergotoxine in senile cerebral insufficiency. In: Geriatric psycho-pharmacology, Nandy K (ed). Amsterdam: Elsevier, 195–212.Google Scholar
  14. Fillenbaum G G (1984): The wellbeing of the elderly: approaches to multidimensional assessment. Geneva: WHO (Offset Publ. N° 84 ).Google Scholar
  15. Folstein M F & al. (1975): “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12: 189–195.Google Scholar
  16. Gaitz C M & al. (1977): Pharmacotherapy for organic brain syndrome in late life: evaluation of an ergot derivative versus placebo. Arch Gen Psychiatry, 34: 839–845.PubMedGoogle Scholar
  17. Grel P, Menard A M (1984): Activité thérapeutique du Duxil sur les troubles intellectuels et psychocomportementaux de l’insuffisance cérébrale chronique. Essai contrôlé à double insu contre placebo. Psychol Méd. 16: 181–189.Google Scholar
  18. Grimley Evans J. (1984): Prevention of age-associated loss of autonomy: epidemiological approaches. 3 Chronic Dis, 37: 353–363.Google Scholar
  19. Harwart D (1979): The treatment of chronic cerebrovascular insufficiency. A double blind study with Pentoxyfilline (Tentai 400). Curr Med Res Opin, 6: 73–84.PubMedCrossRefGoogle Scholar
  20. Heikkinen E & al. (1983): The elderly in eleven countries. A sociomedical survey. Copenhagen: WHO Regional Office for Europe (Public Health in Europe N° 23 ).Google Scholar
  21. Hennes J D (1972): The measurement of levels of Health. Medical Care Review, 229: 1268–88Google Scholar
  22. Holland W W & al. (1979): Measurement of levels of Health. Geneva: WHO (EMRO Technical Publication).Google Scholar
  23. Israël L (1976): Memory disorders as criteria of dependency in old people: evaluation and measurement. In: Dependency or interdependency in old age, Munnichs 3MA, Van Del Heuvel W3A (eds). The Hague: Martinus Nijhoff, 45 - 53.Google Scholar
  24. Israel L & al. (1979): Les troubles de la mémoire chez les personnes âgées: sondage effectué auprès d’une population de 782 retraités de la ville de Grenoble. Rev Gériatr, 4 (9): 455–472.Google Scholar
  25. Israël L, Kozarevic DJ (1982): Multidimensions of health in assessing the elderly. WHO informal meeting on “Measuring cognitive improvement, health and functioning in the elderly”, Geneva, 22–24 Sept.Google Scholar
  26. Israël L, Waintraub L (1983): Méthodes d’évaluations psychométriques en gériatrie: le choix d’un instrument et de ses critères de fiabilité. Presse Méd, 12 (48): 3124–28.Google Scholar
  27. Israël L, Kozarevic Dj (1984a): Review of limitations and problems in multidimensional assessment. Report on a WHO Working Group on “Consultations on guidelines for assessing the functioning of the elderly”, Aberdeen, 27–29 march. Geneva: WHOGoogle Scholar
  28. Israël L, Kozarevic Dj, Sartorius N (1984b): Source Book of Geriatric Assessment. 2 volumes. Basel: Karger.Google Scholar
  29. Israël L (1985a): Memory and mental stimulation: assessment in clinical trials. In: Develpemental Psychology, Brainerd C J, Reyna V F (eds). Amsterdam: Elsevier Science Publishers.Google Scholar
  30. Israël L, Kozarevic Dj (1985b): Geriatric assessment: definition of purposes and validation works. Circul Metabol Cerv, 2 (suppl l): 114–119.Google Scholar
  31. Israël L (1986a): Preventive intervention methods in gerontology: assessment, concepts and strategies. In: Realistic expectations for long life, Lesnoff- Caravaglia G (ed). New York: Human Sciences Press.Google Scholar
  32. Israël L (1986b): Invecchiamento e valutazione dellfanziono. In: Atti del convegno “Fosfatidilserina e qualita della vita nell’invecchiamento cerebrale patologico”, Venezia, 6–7 marzo 1986. Padova: Liviana Editrice.Google Scholar
  33. Israël L & al (1986c): Assessing the dementia(s) in clinical practice and population surveys: review of the literature since 1965. In: Proceedings of the International Symposium “Senile dementiafs 86 early detection”, Paris, 27–29 october 1986. London: John Libbey & Company Limited.Google Scholar
  34. Israël L, Waintraub L (1986d): Comparative studies between drug therapy and mental stimulation. Paper presented at 21ème Congrès International de Psychologie Appliquée, Jerusalem (Israël), 13–18 Juillet 1986.Google Scholar
  35. Israël L (1986e): Cognitive stimulation versus drug therapy and placebo. Presented to 2nd Workshop of International Psychogeriatric Association, Paris 5–6 septembre 1986.Google Scholar
  36. Kane R A, Kane R L (1981): Assessing the elderly: a practical guide to measurement. Lexington, MA Lexington Books.Google Scholar
  37. Kaplan G & al. (1986): Subjective state of health and survival in the elderly. Paper presented at the Fourth Annual Meeting of the Israël Epidemiological Society, Haifa.Google Scholar
  38. Kaplitz S E (1975): Withdrawn apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc, 23: 271–276.PubMedGoogle Scholar
  39. Katz S & al. (1983): Active life expectancy. N Engl J Med, 309: 1218–24.Google Scholar
  40. Kozarevic Dj & al. (1976): The Yugoslavia cardiovascular disease study, I: The incidence of coronary heart disease by area. J Chronic Dis, 29: 404–414.Google Scholar
  41. Kozarevic Dj (1982a): Epidemiological aspects of functional disability and health among the elderly. In: Santé publique et vieillissement, Henrard JC (ed). Paris: INSERM, 167–179. (Colloque de l’INSERM, vol. 101 ).Google Scholar
  42. Kozarevic Dj (1982b): Performance in activities of daily living and clinical data. “Organization of services to prevent disability among the elderly”: paper presented at a WHO working Group, Sokobanja.Google Scholar
  43. Kozarevic Dj (1982c): Health status and performance in activities of daily living in old age. In 2 Preventing disability in the elderly: report on a WHO Working Group, Cologne, 16–19 novembre 1981. Geneva: WHO (EURO Reports and Studies N° 65 ).Google Scholar
  44. Kozarevic Dj & al (1982d): Health and functional abilities. Chapter 2. In: The elderly in eleven countries: a socio-medical survey. Copenhagen, WHO Regional Office for Europe (Public Health in Europe).Google Scholar
  45. Kozarevic Dj (1983) 2 The design of health and social surveys of the elderly Scientific Group on Epidemiology of Aging. Geneva 2 WHO.Google Scholar
  46. Kozarevic Dj (1985) 2 Health and functional ability. WHO Report for “Follow-up of the eleven-countries 2 study on health care of the elderly”, Second meeting of the Steering Group, Jyvaskyla, Finland, 10–12 december.Google Scholar
  47. Kozarevic Dj (1986) 2 Screening for non-communicable deseases in the elderly. Paper presented at WHO Advisory Group on “The effectiveness of health promotion for the elderly”, Hamilton, Ontario 28–30 April.Google Scholar
  48. Lehr U (1986) 2 Aging as fate and challenge 2 the influence of social, biological and psychological factors. In 2 Mental Health of the Elderly, Hafner H & al. (eds). Berlin 2 Springer-Verlag, 57–67.Google Scholar
  49. Levi L (1979) 2 Psychosocial factors in preventive medicine. In 2 Healthy people, the surgeon general’s report on health promotion and disease prevention. Washington, DC 2 US Dept of Health, Education and Welfare ( DHEW/PHS Pubi. N° 79–55071A ).Google Scholar
  50. Linn M W & al. (1968) 2 Cumulative illness rating scale. 3 m Geriatr Soc, 16 (5)2 622.Google Scholar
  51. Loew D M, Singer J M (1983) 2 Stimulants and senility. In 2 Stimulants 2 neurochemical, behavioral and clinical prespectives, Creese I & al. New York 2 Raven Press.Google Scholar
  52. Me Khann G & al. (1984) 2 Clinical diagnosis of Alzheimer’s disease 2 Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology, 34: 939–944.Google Scholar
  53. Mossey J M, Shapiro E (1982) 2 Self-rated health 2 a predictor of mortality among the elderly. Am J Public Health, 72: 800–808.Google Scholar
  54. Nicrosini F, Pasotti C (1976) 2 Studio clinico controllato sull’ attività e sulla tollerabilita del Trivastan. Min Med, 67: 1745–50.Google Scholar
  55. Plutchik R (1979) 2 Conceptual and praticai issues in the assessment of the elderly. In 2 Psychiatric symptoms and cognitive loss in the elderly, Raskin A, Jarvik L F (eds). Washington 2 Hemisphere Publishing Corporation, 19–38.Google Scholar
  56. Prien R F (1973) 2 Chemiotherapy in chronic organic brain syndrome 2 a review of the literature. Psychopharmacol Bull, 925-20.Google Scholar
  57. Rao DB & al. (1977): Cyclandelate in the treatment of senile mental changes: a double-blind evaluation. 3 Am Geriatr Soc, 25: 548–551.Google Scholar
  58. Raskin A & al. (1978): The effects of hyperbaric and normobaric oxygene on cognitive impairment in the elderly. Arch Gen Psychiatry, 35: 50–56.Google Scholar
  59. Rossman I (1983): Comprehensive functional assessment: a commentary. 3 Am Geriatr Soc, 31 (12): 763–765.Google Scholar
  60. Rubenstein L (1983): The clinical effectiveness of multidimensional geriatric assessment. 3 Am Geriatr Soc, 31 (12): 758–762.Google Scholar
  61. Rubenstein L & al. (1984): Systematic biaises in functional status assessment of elderly adults: effects of different data sources. J Gerontol, 39 (6): 686–691.Google Scholar
  62. Scholing W E (1979): Langzeitbehandlung das organischen Psychosyndroms. Psychometrische Untersuchungen mit Piribedil in Retardform. Ther Ggw, 118:66– 84.Google Scholar
  63. Stewart A L & al. (1981): Advances in the measurement of functional status: construction of aggregate indexes. Medical Care, 19 (5): 473–488.Google Scholar
  64. Storer J B (1962): Changes in cells and tissue with age. In: Aging and levels of biological organization, Brues A M, Sacher G D (eds). Chicago: University of Chicago Press, 192-Google Scholar
  65. Thomae H (ed) (1976): Patterns of aging: findings from the Bonn Longitudinal Study of Aging. Basel: Karger.Google Scholar
  66. Thompson LW & al. (1976): Effects of hyperbaric oxygen on behavioral and physiological measures in elderly demented patients. J Gerontol, 31: 23–28.Google Scholar
  67. World Health Organization (1948) : Constitution of the World Health Organization. In : Basic Documents. 15th ed. Geneva : WHO.Google Scholar
  68. World Health Organization (1980): International classification of impairments, disabilities and handicaps: a manual fo classification relating to the consequences of disease. Geneva: WHO.Google Scholar
  69. WHO Scientific Group on the Epidemiology of Aging (1984): The uses of epidemiology in the study of the elderly. (Technical Report Series N° 706).Google Scholar
  70. WHO Committee on Disability, Prevention and Rehabilitation ( 1981: Disability prevention and rehabilitation. Geneva: WHO (Technical Report Series N°668).Google Scholar
  71. WHO Working Group (1982): Preventing disability in the elderly. Copenhagen: WHO Regional Office for Europe (EURO Reports and Studies N° 65 ).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • L. Israël
    • 1
  • Dj. Kozarevic
    • 2
  • J. M. Orgogozo
    • 3
  1. 1.Geriatric CenterUniversity HospitalGrenobleFrance
  2. 2.Institute of Chronic Diseases & Gerontology and Center for Multidisciplinary StudiesUniversity of BeogradBeogradYugoslavia
  3. 3.Neurology UnitPellegrin University HospitalBordeauxFrance

Personalised recommendations